NUCLEIC ACID MOLECULES INSERTED EXPRESSION REGULATION SEQUENCES, EXPRESSION VECTOR COMPRISING NUCLEIC ACID MOLECLUES AND PHARMACEUTICAL USE THEREOF

A nucleic acid molecule including at least one expression control sequence having an Internal Ribosomal Entry Site (IRES) sequence, at least one coding region, and optionally multiple adenosines or thymidines upstream of the at least one expression control sequence is disclosed as an expression syst...

Full description

Saved in:
Bibliographic Details
Main Authors KO, Hae Li, KWAK, Hae Won, NAM, Jae Hwan, PARK, Hyo Jung, KIM, Hun
Format Patent
LanguageEnglish
Published 04.11.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A nucleic acid molecule including at least one expression control sequence having an Internal Ribosomal Entry Site (IRES) sequence, at least one coding region, and optionally multiple adenosines or thymidines upstream of the at least one expression control sequence is disclosed as an expression system. Besides, a recombinant expression vector including the nucleic acid molecule and pharmaceutical or medicinal use of the nucleic acid molecule are disclosed.
AbstractList A nucleic acid molecule including at least one expression control sequence having an Internal Ribosomal Entry Site (IRES) sequence, at least one coding region, and optionally multiple adenosines or thymidines upstream of the at least one expression control sequence is disclosed as an expression system. Besides, a recombinant expression vector including the nucleic acid molecule and pharmaceutical or medicinal use of the nucleic acid molecule are disclosed.
Author KIM, Hun
KO, Hae Li
PARK, Hyo Jung
NAM, Jae Hwan
KWAK, Hae Won
Author_xml – fullname: KO, Hae Li
– fullname: KWAK, Hae Won
– fullname: NAM, Jae Hwan
– fullname: PARK, Hyo Jung
– fullname: KIM, Hun
BookMark eNqNjD0KAjEUBrfQwr87PLBVWF09QHj76QayyZqXiJ2IxEpWQW_ihVWwEGysZoph-lmnvbSplz1sZAPNpFiXVDsDjgZC2gp8QEnYNR4i2lnyWEejwlsFmwjLkMl3sAUH54ld3Xgt2q7p927i665sSU2lfK0YMWhWhqKAQgUPtxpm3dPhfEujDwfZeIXA1TRdL_t0ux6OqU33fZR5Pp8Vi3y5zNWs-K96AiOgRIA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2021340550A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2021340550A13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:46:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2021340550A13
Notes Application Number: US201917050503
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211104&DB=EPODOC&CC=US&NR=2021340550A1
ParticipantIDs epo_espacenet_US2021340550A1
PublicationCentury 2000
PublicationDate 20211104
PublicationDateYYYYMMDD 2021-11-04
PublicationDate_xml – month: 11
  year: 2021
  text: 20211104
  day: 04
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
RelatedCompanies_xml – name: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION
Score 3.3593748
Snippet A nucleic acid molecule including at least one expression control sequence having an Internal Ribosomal Entry Site (IRES) sequence, at least one coding region,...
SourceID epo
SourceType Open Access Repository
SubjectTerms BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Title NUCLEIC ACID MOLECULES INSERTED EXPRESSION REGULATION SEQUENCES, EXPRESSION VECTOR COMPRISING NUCLEIC ACID MOLECLUES AND PHARMACEUTICAL USE THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211104&DB=EPODOC&locale=&CC=US&NR=2021340550A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8MwMIwp6ptOxY8pAWVPFvfRj-1hSJema6Vfts3Y22hnCoJ0w1X8If5hL2HTgbC3JBcOcuE-k7tD6L7bz9qFwQslKzoDRS10rgw0TVdA9GmaZszB4hfJyX6gO0x9nmrTGnrf5MLIOqFfsjgicNQc-L2S8nr5F8Sy5N_K1WP-BkuLJzsdWq21dwzejOhma42GNAqtkLQIGbKkFcQS1gPjRGub4CvtCUNaVNqnk5HIS1luKxX7GO1HgK-sTlCNlw10SDa91xrowF8_ecNwzX2rU_QdMOJRl2CTuBb2Q48S5tEEgwNOwSy1MJ1KgoJ4xDEdM0_Gn3BCX5gIJCUP2xsmlKRhjEnoR7GbuMEY_8fuMcBuBhaOHDP2TUJZKsonYJZQnDo0pqF9hu5smhJHgdPNfok5Y8k2KXrnqF4uSn6BcDfnBdDPyHSuqWr7Nc-6eT_ng36nM1d5YVyi5i5MV7vB1-hITGUWn9pE9erjk9-AOq_yW3kLP9YCmGM
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivNNp-LH1ICyJ4v7aNrtYUiXpmu1H7Ntxt5GO1MQpBuu4h_iP-w1TB0Iewu5cJALd7m75H6H0G2nl7QyXWRKkrX7ipppQukToilg-ggh-hw8_rI42fM1m6uPUzKtoLefWhiJE_opwRFBo-ag74W018u_JJYp_1au7tNXmFo8WPHAbK6jY4hmym625nDAxoEZ0CalAx41_VDSuuCckJYBsdKOXuLzls7TZFjWpSw3LxXrAO2OgV9eHKKKyOuoRn96r9XRnrd-8obhWvtWR-jL59RlDsUGdUzsBS6j3GURhgCcgVtqYjaVAgXziEM24q7MP-GIPfMykRTdbS6YMBoHIaaBNw6dyPFH-D93lwN3wzfx2DZCz6CMxyV8AuYRw7HNQhZYx-jGYjG1Fdjd7FeYMx5tiqJ7gqr5IhenCHdSkYH89EQTRFVbL2nSSXup6Pfa7bkqMv0MNbZxOt9OvkY1O_bcmev4TxdovyTJij61garF-4e4hKu9SK_kiXwDIQGbUA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NUCLEIC+ACID+MOLECULES+INSERTED+EXPRESSION+REGULATION+SEQUENCES%2C+EXPRESSION+VECTOR+COMPRISING+NUCLEIC+ACID+MOLECLUES+AND+PHARMACEUTICAL+USE+THEREOF&rft.inventor=KO%2C+Hae+Li&rft.inventor=KWAK%2C+Hae+Won&rft.inventor=NAM%2C+Jae+Hwan&rft.inventor=PARK%2C+Hyo+Jung&rft.inventor=KIM%2C+Hun&rft.date=2021-11-04&rft.externalDBID=A1&rft.externalDocID=US2021340550A1